Nasdaq Stocks Update: Propanc Biopharma Shares Rise Following Debut

Propanc Biopharma's shares advanced following its Nasdaq debut. Other notable news includes global stocks drifting as traders await Ukraine talks and Jackson Hole, Dow ending higher after UnitedHealth gains, and blank check companies Talon Capital Corp and Cantor Equity Partners V filing for IPOs. Soligenix Inc received a Nasdaq notice for non-compliance with equity requirements, while Gemini Space Station Inc and Youxin Technology Ltd received notifications regarding minimum bid and market value of listed securities requirements. Guardant Health and Schrödinger reported inducement grants. Monkey Tree Investment Ltd said its IPO price is expected between $4 and $5 per share.

On August 18, 2025, Propanc Biopharma's stock surged by 254.7% in pre-market trading, marking a significant milestone for the biopharmaceutical company. This substantial increase came following its successful uplisting to the Nasdaq, opening at $4.00 per share [1].

The company's stock has shown resilience despite recent volatility, with a notable increase of 12.41% to $3.35 in recent trading sessions. This positive momentum reflects investor confidence in the company's strategic direction and potential for long-term success [1].

Propanc Biopharma has also been actively engaged in fundraising efforts, announcing a $4 million public offering. This capital infusion is likely aimed at supporting ongoing research and development initiatives, which could drive future growth and innovation [1].

Other notable market movements include global stocks drifting as traders await Ukraine talks and the Jackson Hole meeting. The Dow ended higher after UnitedHealth gains, while other indexes slipped on rate cut uncertainty [2].

Blank check companies Talon Capital Corp and Cantor Equity Partners V filed for IPOs of up to $225 million and $200 million, respectively [2]. Soligenix Inc received a Nasdaq notice for non-compliance with equity requirements, while Gemini Space Station Inc and Youxin Technology Ltd received notifications regarding minimum bid and market value of listed securities requirements [2].

Guardant Health and Schrödinger reported inducement grants to new non-executive employees [2, 3]. Monkey Tree Investment Ltd said its IPO price is expected between $4 and $5 per share [2].

References:
[1] https://www.ainvest.com/news/propanc-biopharma-stock-soars-254-7-nasdaq-uplisting-2508/
[2] https://www.marketscreener.com/news/blank-check-company-talon-capital-corp-files-for-ipo-of-up-to-225-million-ce7c51ded080f32d
[3] https://www.businesswire.com/news/home/20250815731741/en/Guardant-Health-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4